APA

Jones F. E., Murray L. S., McNeilly S., Dean A., Aman A., Lu Y., Nikolova N., Malomgré R., Horsburgh K., Holmes W. M., Kadler K. E. & Van Agtmael T. (20190621). 4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease. : Human molecular genetics.

Chicago

Jones Frances E, Murray Lydia S, McNeilly Sarah, Dean Afshan, Aman Alisha, Lu Yinhui, Nikolova Nija, Malomgré Ruben, Horsburgh Karen, Holmes William M, Kadler Karl E and Van Agtmael Tom. 20190621. 4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease. : Human molecular genetics.

Harvard

Jones F. E., Murray L. S., McNeilly S., Dean A., Aman A., Lu Y., Nikolova N., Malomgré R., Horsburgh K., Holmes W. M., Kadler K. E. and Van Agtmael T. (20190621). 4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease. : Human molecular genetics.

MLA

Jones Frances E, Murray Lydia S, McNeilly Sarah, Dean Afshan, Aman Alisha, Lu Yinhui, Nikolova Nija, Malomgré Ruben, Horsburgh Karen, Holmes William M, Kadler Karl E and Van Agtmael Tom. 4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease. : Human molecular genetics. 20190621.